Download PDF
Thromb Haemost 1973; 29(03): 562-571
DOI: 10.1055/s-0038-1647797
Original Article
Schattauer GmbH

A New Congenital Abnormality of Human Fibrinogen

Fibrinogen Bethesda II[*]
H. R Gralnick
1   Hematology Service, Clinical Pathology Department and Division of Biologics Standards, National Institutes of Health, Bethesda, Maryland 20014
,
H. M Givelber
1   Hematology Service, Clinical Pathology Department and Division of Biologics Standards, National Institutes of Health, Bethesda, Maryland 20014
,
J. S Finlayson
1   Hematology Service, Clinical Pathology Department and Division of Biologics Standards, National Institutes of Health, Bethesda, Maryland 20014
› Author Affiliations
Further Information

Publication History

Publication Date:
30 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

A dysfibrinogenemia (fibrinogen Bethesda II) was recognized in a Caucasian family with no history of bleeding or thrombosis. Thrombin and Reptilase times were prolonged, and there was a discrepancy between the fibrinogen levels determined by the fibrin tyrosine content and the Clauss method. Other coagulation and fibrinolytic measurements yielded normal values. The half-life of homologous and autologous 125I-fibrinogen in the propositus was approximately 20% shorter than the mean (3.70 ±0.45 days) of normal individuals. Fibrinogen Bethesda II exhibited normal migration during electrophoresis in polyacrylamide gel (in the presence of sodium dodecyl sulfate) or cellulose acetate, normal ultracentrifugal behavior, a normal chromatographic elution pattern and normal levels of hexose and sialic acid. Upon immunoelectrophoresis of whole plasma, the arc was more anodal than that produced by the fibrinogen of normal plasma. Functionally, fibrinogen Bethesda II prolonged the thrombin and Reptilase times of normal plasma and fibrinogen. The rate at which fibrinopeptides were released by thrombin or ancrod was similar to that for normal fibrinogen, and the amounts eventually reached the same levels, but a slight delay was consistently observed in the early stages of the reaction. Aggregation of fibrin monomers prepared with either thrombin or Reptilase was markedly abnormal, whereas the crosslinking (as assessed by polyacrylamide gel electrophoresis) did not differ from that of normal fibrin.

* A summary of these results was presented at the III Congress of the International Society on Thrombosis and Haemostasis, Washington, D. C., 1972.


 

  • References

  • 1 Ashwell G. 1966. New colorimetric methods of sugar analysis. In: Colowick S. P, Kaplan N. O. (ed.), Methods in Enzymology. Vol. 8, Academic Press; New York and London: 85.
    Search in Google Scholar
  • 2 Beck E. A, Shainoff J. R, Vogel A, Jackson D. P. 1971; Functional evaluation of an inherited abnormal fibrinogen: fibrinogen “Baltimore”. Journal of Clinical Investigation 50: 1874.
    CrossrefPubMedSearch in Google Scholar
  • 3 Belitser V. A, Varetskaja T. V, Malneva G. V. 1968; Fibrinogen-fibrin interaction. Biochimica et Biophysica Acta 154: 367.
    CrossrefPubMedSearch in Google Scholar
  • 4 Blombäck B, Blombäck M. 1970; Molecular defects and variants of fibrinogen. Nouvelle Revue Française D’Hématologie 10: 671.
    PubMedSearch in Google Scholar
  • 5 Correll J. T, Sjoerdsma A. 1962; Inhibition of a human fibrinolytic system by normal and pathologic sera. Proceedings of the Society for Experimental Biology and Medicine 111: 274.
    PubMedSearch in Google Scholar
  • 6 von Felten A, Dückert F, Frick P. G. 1966; Familial disturbance of fibrin monomer aggregation. British Journal of Haematology 12: 667.
    CrossrefPubMedSearch in Google Scholar
  • 7 Finlayson J. S, Mosesson M. W. 1963; Heterogeneity of human fibrinogen. Biochemistry 02: 42.
    CrossrefPubMedSearch in Google Scholar
  • 8 Forman W. B, Ratnoff O. D, Boyer M. H. 1968; An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland. Journal of Laboratory and Clinical Medicine 72: 455.
    PubMedSearch in Google Scholar
  • 9 Gralnick H. R, Finlayson J. S. 1972; Congenital dysfibrinogenemias. Annals of Internal Medicine 77: 471.
    CrossrefPubMedSearch in Google Scholar
  • 10 Gralnick H. R, Givelber H. M, Shainoff J. R, Finlayson J. S. 1971; Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release. Journal of Clinical Investigation 50: 1819.
    CrossrefPubMedSearch in Google Scholar
  • 11 Hasselback R, Marion R. B, Thomas J. W. 1963; Congenital hypofibrinogenemia in five members of a family. Canadian Medical Association Journal 88: 19.
    PubMedSearch in Google Scholar
  • 12 Imperato C, Dettori A. G. 1958; Ipofibrinogenemia congenita con fibrinoastenia. Helvetica Paediatrica Acta 13: 380.
    PubMedSearch in Google Scholar
  • 13 Krause W. H, Heene D. L, Zimmermann P, Lasch H. G. 1972. Congenital dysfibrinogenemia (fibrinogen Giessen). In: III Congress of the International Society on Thrombosis and Haemostasis. Washington: 22-26 August 1972 112.
    Search in Google Scholar
  • 14 Krause W. H, Heene D. L, Zimmermann P, Lasch H. G. 1973; Congenital dysfibrinogenemia (fibrinogen Giessen). Thrombosis et Diathesis Haemorrhagica 29: 547.
    PubMedSearch in Google Scholar
  • 15 Lacombe M, Soria J, Soria C, d’Angelo G, Lavallée R, Bonny Y. 1972. A new case of congenital dysfibrinogenemia without bleeding tendency: the fibrinogen “Montreal”. In: III Congress of the International Society on Thrombosis and Haemostasis. Washington: 22-26 August 1972 114.
    Search in Google Scholar
  • 16 Lacombe M, Soria J, Soria C, D’Angelo G, Lavallée R, Bonny Y. 1973; Fibrinogen Montreal. A new case of congenital dysfibrinogenemia with defective aggregation of monomers. Thrombosis et Diathesis Haemorrhagica 29: 536.
    PubMedSearch in Google Scholar
  • 17 Lorand L. 1952; Fibrino-peptide. Biochemical Journal 52: 200.
    CrossrefPubMedSearch in Google Scholar
  • 18 Lowry O. H, Rosebrough N. J, Farr A. L, Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265.
    PubMedSearch in Google Scholar
  • 19 Mammen E. F, Prasad A. S, Barnhart M. I, Au O. C. 1969; Congenital dysfibrinogenemia: fibrinogen Detroit. Journal of Clinical Investigation 48: 235.
    CrossrefPubMedSearch in Google Scholar
  • 20 Martinez J, Holburn R. R, Shapiro S. S, Erslev A. J. 1972; Hereditary hypodys- fibrinogenemia characterized by fibrinogen hypercatabolism. Journal of Clinical Investigation 51: 62a.
    PubMedSearch in Google Scholar
  • 21 McKee P. A, Mattock P, Hill R. L. 1970; Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proceedings of the National Academy of Sciences USA 66: 738.
    CrossrefPubMedSearch in Google Scholar
  • 22 Ménaché D. 1964; Constitutional and familial abnormal fibrinogen. Thrombosis et Diathesis Haemorrhagica, Suppl 13: 173.
    PubMedSearch in Google Scholar
  • 23 Mosesson M. W, Sherry S. 1966; The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry 05: 2829.
    CrossrefPubMedSearch in Google Scholar
  • 24 Ratnoff O. D, Menzie C. 1951; A new method for the determination of fibrinogen in small samples of plasma. Journal of Laboratory and Clinical Medicine 37: 316.
    PubMedSearch in Google Scholar
  • 25 Samama M, Soria J, Soria C, Bousser J. 1969; Dysfibrinogénémie congénitale et familiale sans tendance hémorragique. Nouvelle Revue Française D’Hématologie 09: 817.
    PubMedSearch in Google Scholar
  • 26 Sherman L. A, Gaston L. W, Kaplan M. E, Spivack A. R. 1972; Fibrinogen St. Louis: a new inherited fibrinogen variant, coincidentally associated with hemophilia A. Journal of Clinical Investigation 51: 590.
    PubMedSearch in Google Scholar
  • 27 Soria J, Soria C, Samama M, Poirot E, Kling C. 1972; a Fibrinogen Troyes -fibrinogen Metz: two new cases of congenital dysfibrinogenemia. Thrombosis et Diathesis Hemorrhagica 27: 619.
    PubMedSearch in Google Scholar
  • 28 Soria J, Soria C, Boulard C. 1972; b Anomalie de structure du fibrinogene »Metz«, localisée sur la chaine a (A) de la molécule. Biochemie 54: 415.
    CrossrefPubMedSearch in Google Scholar
  • 29 Streiff F, Alexandre P, Vigneron C, Soria J, Soria C, Mester L. 1971; Un nouveau cas d’anomalie constitutionnelle et familiale du fibrinogéne sans diathese hémorragique. Thrombosis et Diathesis Haemorrhagica 26: 565.
    PubMedSearch in Google Scholar
  • 30 Takeda Y. 1966; Studies on the metabolism and distribution of fibrinogen in healthy men with autologous 125I-labelled fibrinogen. Journal of Clinical Investigation 45: 103.
    CrossrefPubMedSearch in Google Scholar
  • 31 Weber K, Osborn M. 1969; The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. Journal of Biological Chemistry 244: 4406.
    PubMedSearch in Google Scholar